Fentanyl Testing in Hospitals
January 12, 2023 11:24 AM to All Senate Members
Circulated By
Senator Doug Mastriano
R Senate District 33
Along With
Sen. Michele Brooks
R Senate District 50
Memo
In the near future, we plan to introduce legislation that will require a general acute care hospital to include testing for fentanyl in a urine drug screening if the hospital conducts a urine drug screening to assist in diagnosing the patient’s condition.
Fentanyl is now the number one cause of death for Americans ages 18-45. This overdose crisis has affected communities across the commonwealth.
Testing for fentanyl can play a key role in saving someone’s life. It can alert a provider that a patient has fentanyl in their system, warn a patient they have ingested fentanyl, or connect people to treatment or a prescription for naloxone.
Most current routine hospital drug screens do not capture fentanyl use and some patients are unaware that they are using fentanyl, as it is increasingly found in methamphetamines, cocaine, and counterfeit drugs such as Xanax.
Fortunately, rapid fentanyl testing does exist. There are three low-cost reagents currently approved by the FDA that can be used with a chemical analyzer to determine if an individual has fentanyl in their system.
Our legislation will ensure that fentanyl is included in drug toxicological testing at all hospitals.
Please join us as a co-sponsor to combat the fentanyl overdose crisis and potentially save lives.
Fentanyl is now the number one cause of death for Americans ages 18-45. This overdose crisis has affected communities across the commonwealth.
Testing for fentanyl can play a key role in saving someone’s life. It can alert a provider that a patient has fentanyl in their system, warn a patient they have ingested fentanyl, or connect people to treatment or a prescription for naloxone.
Most current routine hospital drug screens do not capture fentanyl use and some patients are unaware that they are using fentanyl, as it is increasingly found in methamphetamines, cocaine, and counterfeit drugs such as Xanax.
Fortunately, rapid fentanyl testing does exist. There are three low-cost reagents currently approved by the FDA that can be used with a chemical analyzer to determine if an individual has fentanyl in their system.
Our legislation will ensure that fentanyl is included in drug toxicological testing at all hospitals.
Please join us as a co-sponsor to combat the fentanyl overdose crisis and potentially save lives.
Legislation
Document - Introduced as SB 683
Last updated on January 12, 2023 11:26 AM
Fentanyl Testing in Hospitals
January 12, 2023 11:24 AM to All Senate Members
Circulated By
MASTRIANO and BROOKS
Memo
In the near future, we plan to introduce legislation that will require a general acute care hospital to include testing for fentanyl in a urine drug screening if the hospital conducts a urine drug screening to assist in diagnosing the patient’s condition.
Fentanyl is now the number one cause of death for Americans ages 18-45. This overdose crisis has affected communities across the commonwealth.
Testing for fentanyl can play a key role in saving someone’s life. It can alert a provider that a patient has fentanyl in their system, warn a patient they have ingested fentanyl, or connect people to treatment or a prescription for naloxone.
Most current routine hospital drug screens do not capture fentanyl use and some patients are unaware that they are using fentanyl, as it is increasingly found in methamphetamines, cocaine, and counterfeit drugs such as Xanax.
Fortunately, rapid fentanyl testing does exist. There are three low-cost reagents currently approved by the FDA that can be used with a chemical analyzer to determine if an individual has fentanyl in their system.
Our legislation will ensure that fentanyl is included in drug toxicological testing at all hospitals.
Please join us as a co-sponsor to combat the fentanyl overdose crisis and potentially save lives.
Fentanyl is now the number one cause of death for Americans ages 18-45. This overdose crisis has affected communities across the commonwealth.
Testing for fentanyl can play a key role in saving someone’s life. It can alert a provider that a patient has fentanyl in their system, warn a patient they have ingested fentanyl, or connect people to treatment or a prescription for naloxone.
Most current routine hospital drug screens do not capture fentanyl use and some patients are unaware that they are using fentanyl, as it is increasingly found in methamphetamines, cocaine, and counterfeit drugs such as Xanax.
Fortunately, rapid fentanyl testing does exist. There are three low-cost reagents currently approved by the FDA that can be used with a chemical analyzer to determine if an individual has fentanyl in their system.
Our legislation will ensure that fentanyl is included in drug toxicological testing at all hospitals.
Please join us as a co-sponsor to combat the fentanyl overdose crisis and potentially save lives.
Document
Introduced as SB 683
Last Updated
January 12, 2023 11:26 AM
Generated 04/28/2025 06:22 AM